Core Viewpoint - 瑞丽医美 (02135.HK) reported a significant decline in revenue and an increase in losses for the first half of 2025, indicating challenges in the medical aesthetics industry due to intense competition and a decrease in active customer numbers [1] Financial Performance - The company's revenue for the first half of 2025 was RMB 84.598 million, representing a year-on-year decrease of 27.99% [1] - The loss attributable to the parent company for the period was RMB 7.57 million, compared to a loss of RMB 1.617 million in the same period last year [1] - Basic loss per share was 1.36 cents [1] Revenue Breakdown - Revenue from medical aesthetic services was approximately RMB 74.90 million, a decline of about 9.7% compared to approximately RMB 83.00 million for the six months ending June 30, 2024 [1] - The decrease in revenue was attributed to a drop in the number of active customers, which could not be offset by an increase in average transaction value [1] - Both minimally invasive beauty services and skin beauty services experienced a reduction in revenue [1]
瑞丽医美(02135.HK)上半年净亏损757万元